Tonix Pharmaceuticals Holding TNXP Cash Flow Statement (2010-2026)

NASDAQ TNXP
$5.78 +0.05 (+0.87%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Tonix Pharmaceuticals Holding Quarterly Cash Flow Statement

Periods 62 quarters
Latest Jun 2026

Tonix Pharmaceuticals Holding reported cash from operations of -$42.24M and free cash flow of -$42.83M for the quarter ended Jun 2026, down 184.8% year over year. This cash flow statement covers 62 quarters of results from Dec 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-18.53M-29.55M-26.42M-23.14M-28.98M-31.68M-33.01M-28.36M-27.98M-27.32M-14.94M-78.78M-14.21M-22.11M-16.83M-28.27M-32.01M-46.91M-40.19M-40.55M
Depreciation and DepletionDep. & Depletion
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.30M0.13M0.21M0.20M0.07M1.77M
Depreciation & Amortization (CF)Dep. & Amort.
0.01M0.03M0.06M0.10M0.25M0.84M0.89M0.90M1.22M1.26M1.21M1.21M0.51M0.50M0.49M0.48M0.46M0.49M0.56M0.62M
Share-based CompensationStock Comp.
2.30M2.30M2.62M2.81M2.77M2.72M2.79M2.36M2.08M2.04M1.69M1.15M1.04M0.89M0.88M1.42M1.92M1.79M1.97M2.26M
Gains from Sales and DivestituresGains Divest
-0.13M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
58.96M-0.96M-0.65M
Other non-cash itemsOther Non-Cash
-7.01M0.86M2.09M
Change in Working Capital
Change in ReceivablesChange Receivables
1.64M-1.30M-0.37M-0.99M1.19M2.79M2.55M2.99M
Change in InventoryChange Inventory
-1.29M-1.16M-1.25M-0.05M-0.27M0.13M-1.22M-0.36M-2.37M2.90M
Change in Account PayablesChange Payables
4.56M0.16M-3.11M1.55M-2.52M3.03M0.58M-1.15M1.02M-3.94M2.98M3.73M-6.36M0.58M-0.35M3.06M1.02M-0.74M1.53M-0.60M
Change in Accured ExpensesChange Accured Exp.
-0.73M2.90M-2.03M-0.28M1.31M2.21M-2.96M1.36M-1.05M4.43M-1.75M0.91M0.48M1.55M-2.95M3.36M1.25M10.08M-2.06M1.75M
Change in Other Operating AssetsOther Assets Change
0.57M-1.74M2.17M2.22M-3.63M-0.59M1.21M-1.47M-3.07M1.76M1.36M-2.37M0.34M-2.94M0.62M-0.13M1.68M1.00M4.02M-0.09M
Change in Other Operating LiabilitiesOther Liabilities Change
0.01M0.00M0.00M0.00M0.00M0.00M-0.01M0.01M0.02M0.01M0.00M0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.29M0.08M0.08M
Other Working Capital ChangesOther WC Changes
-0.56M1.73M-2.17M-2.21M3.63M0.59M-1.21M1.49M3.08M-1.75M-1.35M2.36M-0.35M2.94M-0.62M0.13M-1.68M-1.29M-3.94M0.17M
Cash from OperationsCash from Ops.
-12.95M-22.45M-31.05M-21.17M-23.54M-22.30M-32.91M-23.37M-23.39M-22.34M-17.58M-9.92M-18.80M-14.63M-16.58M-14.83M-28.78M-39.65M-42.32M-42.24M
Investing Activities
Capital ExpendituresCapex
7.75M25.62M20.22M14.44M8.82M4.67M3.80M1.85M1.81M0.44M0.11M0.01M0.00M0.01M0.53M0.96M1.87M1.69M0.59M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M
Change in Property, Plant and EquipmentChange in PP&E
-7.75M-25.62M-20.22M-14.44M-8.82M-4.67M-3.80M-1.85M-1.81M-0.43M-0.11M-0.01M0.00M-0.01M-0.53M-0.96M-1.87M-1.69M-0.59M
Purchase of InvestmentsInvestments Purchased
Sale and Maturity of InvestmentsInvestments Sold
Other Investing ActivitiesOther investing
0.85M
Cash from Investing ActivitiesCash from Investing
-7.75M-25.62M-20.22M-14.44M-8.82M-4.67M-3.80M-24.02M-0.82M-0.43M-0.11M-0.01M0.00M-0.01M-2.54M-0.96M-1.02M-1.69M-0.59M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
Long-Term Debt RepaymentsLT Debt Repayment
0.24M0.71M0.71M0.71M9.65M
Non-Current Debt
-0.24M-0.71M-0.71M-0.71M-9.65M
Current Debt
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.24M-0.71M-0.71M-0.71M-9.65M
Change in Capital Stock
Common Stock IssuedStock Issued
37.96M43.77M13.06M44.93M26.88M9.63M2.47M1.03M6.27M31.77M0.02M10.73M43.61M85.86M62.23M13.90M94.86M66.95M20.21M33.51M
Shares Repurchased
13.97M3.05M2.90M7.81M
Net Shares Issued and RepurchasedNet Shares Issued
37.96M43.77M13.06M44.93M26.88M9.63M-11.50M1.03M6.27M31.77M0.02M10.73M43.61M85.86M59.18M10.99M94.86M59.14M20.21M33.51M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
-2.40M
Net Equity Issued and RepurchasedNet Equity Issued
37.96M43.77M13.06M44.93M26.88M7.23M-11.50M1.03M6.27M31.77M0.02M10.73M43.61M85.86M59.18M10.99M94.86M59.14M20.21M33.51M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
37.96M43.77M13.06M72.18M-4.63M7.23M-11.50M1.03M6.27M40.71M-0.21M7.03M42.91M85.15M49.53M10.99M94.86M59.14M20.21M33.51M
Additional items
Exchange Rate EffectFX Effect
-0.01M-0.01M-0.03M-0.02M-0.02M-0.01M-0.04M-0.01M-0.01M0.00M0.00M-0.02M0.02M-0.01M0.00M0.00M-0.01M0.01M-0.06M
Change in Cash
17.25M-4.31M-38.23M36.54M-37.00M-19.75M-48.25M-46.36M-17.94M17.93M-17.90M-2.89M24.08M70.55M32.94M-6.38M65.11M18.46M-23.80M-9.39M
Ending Cash Balance
Free Cash FlowFCF
-20.70M-48.07M-51.26M-35.61M-32.36M-26.97M-36.71M-25.21M-25.20M-22.78M-17.68M-9.92M-18.81M-14.63M-16.59M-15.36M-29.74M-41.52M-44.01M-42.83M
Net Cash FlowNCF
17.26M-4.30M-38.20M36.57M-36.98M-19.74M-48.21M-46.36M-17.93M17.94M-17.90M-2.89M24.10M70.52M32.95M-6.38M65.12M18.47M-23.81M-9.33M
Interest Paid
0.30M0.28M0.12M-0.03M

Tonix Pharmaceuticals Holding Cash Flow Statement API

Pull Tonix Pharmaceuticals Holding's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=TNXP&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY